CBOE
Price
$375.42Alerts
Change
+$6.53 (+1.77%)
Updated
Nov 13 closing price
Capitalization
36.89B
75 days until earnings call
Intraday BUY SELL Signals
GEHC
Price
$83.02Alerts
Change
+$1.18 (+1.44%)
Updated
Nov 13 closing price
Capitalization
37.21B
Intraday BUY SELL Signals
Interact to see
Advertisement

CBOE vs GEHC

CBOE vs GEHC Comparison Chart in %
View a ticker or compare two or three
VS
CBOE vs. GEHC commentary
Nov 16, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CBOE is a Buy and GEHC is a Buy.

Interact to see
Advertisement
SUMMARIES
A.I.Advisor
a Summary for CBOE with price predictions
Nov 13, 2026

CBOE in upward trend: price rose above 50-day moving average on October 08, 2026

CBOE moved above its 50-day moving average on October 08, 2026 date and that indicates a change from a downward trend to an upward trend. In 36 of 51 similar past instances, the stock price increased further within the following month. The odds of a continued upward trend are 71%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The 10-day moving average for CBOE crossed bullishly above the 50-day moving average on October 14, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 13 of 19 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 68%.

The 50-day moving average for CBOE moved above the 200-day moving average on October 21, 2026. This could be a long-term bullish signal for the stock as the stock shifts to an upward trend.

Following a +4.65% 3-day Advance, the price is estimated to grow further. Considering data from situations where CBOE advanced for three days, in 203 of 322 cases, the price rose further within the following month. The odds of a continued upward trend are 63%.

The Aroon Indicator entered an Uptrend today. In 172 of 272 cases where CBOE Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 63%.

Bearish Trend Analysis

The RSI Indicator demonstrates that the ticker has stayed in the overbought zone for 3 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 8 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where CBOE declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 42%.

CBOE broke above its upper Bollinger Band on November 02, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is 5 (best 1 - 100 worst), indicating outstanding price growth. CBOE’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is 20 (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 72, placing this stock better than average.

The Tickeron SMR rating for this company is 37 (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is 48 (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Valuation Rating of 90 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (6.558) is normal, around the industry mean (4.143). P/E Ratio (27.449) is within average values for comparable stocks, (19.659). Projected Growth (PEG Ratio) (2.241) is also within normal values, averaging (1.780). Dividend Yield (0.010) settles around the average of (0.017) among similar stocks. P/S Ratio (5.615) is also within normal values, averaging (7.166).

A.I.Advisor
a Summary for GEHC with price predictions
Nov 13, 2026

GEHC sees its 50-day moving average cross bullishly above its 200-day moving average

The 50-day moving average for GEHC moved above the 200-day moving average on November 11, 2026. This could be a long-term bullish signal for the stock as the stock shifts to an upward trend.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on October 12, 2026. You may want to consider a long position or call options on GEHC as a result. In 44 of 69 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 64%.

GEHC moved above its 50-day moving average on October 15, 2026 date and that indicates a change from a downward trend to an upward trend.

The 10-day moving average for GEHC crossed bullishly above the 50-day moving average on October 22, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 10 of 14 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 71%.

Following a +7.87% 3-day Advance, the price is estimated to grow further. Considering data from situations where GEHC advanced for three days, in 155 of 224 cases, the price rose further within the following month. The odds of a continued upward trend are 69%.

The Aroon Indicator entered an Uptrend today. In 94 of 169 cases where GEHC Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 56%.

Bearish Trend Analysis

The 10-day RSI Indicator for GEHC moved out of overbought territory on November 11, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 32 similar instances where the indicator moved out of overbought territory. In 17 of the 32 cases, the stock moved lower in the following days. This puts the odds of a move lower at 53%.

The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In 29 of 46 cases where GEHC's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are 63%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where GEHC declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 60%.

GEHC broke above its upper Bollinger Band on November 02, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is 9 (best 1 - 100 worst), indicating outstanding price growth. GEHC’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is 18 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is 48 (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Valuation Rating of 74 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (3.390) is normal, around the industry mean (4.142). P/E Ratio (18.938) is within average values for comparable stocks, (3.291). Projected Growth (PEG Ratio) (1.666) is also within normal values, averaging (11.253). Dividend Yield (0.002) settles around the average of (0.011) among similar stocks. P/S Ratio (1.363) is also within normal values, averaging (40.124).

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. GEHC’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.

FUNDAMENTALS RATINGS
CBOE: Fundamental Ratings
CBOE
OUTLOOK RATING
1..100
45
VALUATION
overvalued / fair valued / undervalued
1..100
90
Overvalued
PROFIT vs RISK RATING
1..100
20
SMR RATING
1..100
37
PRICE GROWTH RATING
1..100
5
P/E GROWTH RATING
1..100
48
SEASONALITY SCORE
1..100
47

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
CBOEGEHC
RSI
ODDS (%)
Bearish Trend 3 days ago
47%
Bearish Trend 3 days ago
53%
Stochastic
ODDS (%)
Bearish Trend 3 days ago
52%
Bearish Trend 3 days ago
63%
Momentum
ODDS (%)
N/A
Bullish Trend 5 days ago
64%
MACD
ODDS (%)
N/A
N/A
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
64%
Bullish Trend 3 days ago
67%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
61%
Bullish Trend 3 days ago
66%
Advances
ODDS (%)
Bullish Trend 5 days ago
63%
Bullish Trend 12 days ago
69%
Declines
ODDS (%)
Bearish Trend 18 days ago
42%
Bearish Trend 4 days ago
60%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
55%
Bearish Trend 3 days ago
61%
Aroon
ODDS (%)
Bullish Trend 3 days ago
63%
Bullish Trend 3 days ago
56%
COMPARISON
Comparison
Nov 16, 2026
Stock price -- (CBOE: $375.42 vs. GEHC: $83.02)
Brand notoriety: CBOE and GEHC are both not notable
CBOE represents the Financial Publishing/Services, while GEHC is part of the Medical/Nursing Services industry
Current volume relative to the 65-day Moving Average: CBOE: 78% vs. GEHC: 59%
Market capitalization -- CBOE: $36.89B vs. GEHC: $37.21B
CBOE [@Financial Publishing/Services] is valued at $36.89B. GEHC’s [@Medical/Nursing Services] market capitalization is $37.21B. The market cap for tickers in the [@Financial Publishing/Services] industry ranges from $1.27M to $137.91B. The market cap for tickers in the [@Medical/Nursing Services] industry ranges from $837 to $190.22B. The average market capitalization across the [@Financial Publishing/Services] industry is $46.28B. The average market capitalization across the [@Medical/Nursing Services] industry is $6.17B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CBOE’s FA Score shows that 2 FA rating(s) are green while GEHC’s FA Score has 2 green FA rating(s).

  • CBOE’s FA Score: 2 green, 3 red.
  • GEHC’s FA Score: 2 green, 3 red.
According to our system of comparison, CBOE is a better buy in the long-term than GEHC.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CBOE’s TA Score shows that 5 TA indicator(s) are bullish while GEHC’s TA Score has 6 bullish TA indicator(s).

  • CBOE’s TA Score: 5 bullish, 4 bearish.
  • GEHC’s TA Score: 6 bullish, 4 bearish.
According to our system of comparison, GEHC is a better buy in the short-term than CBOE.

Price Growth

CBOE (@Financial Publishing/Services) experienced а +6.27% price change this week, while GEHC (@Medical/Nursing Services) price change was +0.78% for the same time period.

The average weekly price growth across all stocks in the @Financial Publishing/Services industry was +0.29%. For the same industry, the average monthly price growth was +8.02%, and the average quarterly price growth was +14.02%.

The average weekly price growth across all stocks in the @Medical/Nursing Services industry was +1.37%. For the same industry, the average monthly price growth was -4.49%, and the average quarterly price growth was -5.80%.

Reported Earning Dates

CBOE is expected to report earnings on Jan 29, 2027.

Industries' Descriptions

@Financial Publishing/Services (+0.29% weekly)

The financial publishing /services sector includes companies that provide informational products and services that are of value to investors, financial/analytics professionals and other interested readers. The products include real-time stock quotes, financial news and analyses. Think S&P Global, Inc., Moody`s Corporation, Thomson-Reuters Corp and IHS Markit Ltd. Information is critical in making financial or investment decisions, and what makes this industry’s output relevant at all times, across various economic conditions.

@Medical/Nursing Services (+1.37% weekly)

The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.

View a ticker or compare two or three
Interact to see
Advertisement

CBOE and

Correlation & Price change

A.I.dvisor indicates that over the last year, CBOE has been loosely correlated with CME. These tickers have moved in lockstep 60% of the time. This A.I.-generated data suggests there is some statistical probability that if CBOE jumps, then CME could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CBOE
1D Price
Change %
CBOE100%
+1.77%
CME - CBOE
60%
Loosely correlated
+0.78%
ICE - CBOE
30%
Poorly correlated
+0.37%
MKTX - CBOE
29%
Poorly correlated
+0.04%
TW - CBOE
29%
Poorly correlated
+0.84%
ARBK - CBOE
22%
Poorly correlated
-1.77%
More

GEHC and

Correlation & Price change

A.I.dvisor indicates that over the last year, GEHC has been loosely correlated with CPAY. These tickers have moved in lockstep 60% of the time. This A.I.-generated data suggests there is some statistical probability that if GEHC jumps, then CPAY could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GEHC
1D Price
Change %
GEHC100%
+1.44%
CPAY - GEHC
60%
Loosely correlated
+1.36%
PHG - GEHC
57%
Loosely correlated
+0.97%
EEFT - GEHC
57%
Loosely correlated
+1.46%
GEN - GEHC
56%
Loosely correlated
+2.39%
ROP - GEHC
54%
Loosely correlated
+0.44%
More
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
WTF2.020.07
+3.59%
Waton Financial Limited
AKR20.21-0.04
-0.20%
Acadia Realty Trust
LINC22.81-0.17
-0.74%
Lincoln Educational Services Corp
RBC485.55-3.62
-0.74%
RBC Bearings
APUS2.23-0.04
-1.76%
Apimeds Pharmaceuticals US Inc.